| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/27/2006 | US20060165786 Methods for treating circadian rhythm phase disturbances |
| 07/27/2006 | US20060165785 Method of chemically stabilizing pharmaceutical formulations with cholesterol |
| 07/27/2006 | US20060165784 Calcium supplement |
| 07/27/2006 | US20060165783 Compacted lactic acid menthyl ester |
| 07/27/2006 | US20060165782 Solid compositions comprising gabapentin having improved stability |
| 07/27/2006 | US20060165781 Orally disintegrating tablets and process for obtaining them |
| 07/27/2006 | US20060165780 Anticoagulant composition |
| 07/27/2006 | US20060165779 Novel method stabilizing bupropion hydrochloride tablets |
| 07/27/2006 | US20060165778 Enteric composition for the manufacture of soft capsule wall |
| 07/27/2006 | US20060165777 to provide an encapsulated dosage form that can be used advantageously both as a whole capsule and that can be opened to allow convenient use of only a portion of the contents therein; allows inhibiting a patient from subdividing such tablet when not so desired by a prescriber |
| 07/27/2006 | US20060165776 Antidepressant oral pharmaceutical compositions |
| 07/27/2006 | US20060165775 Capsule and film-forming composition comprising gum arabic |
| 07/27/2006 | US20060165774 Non gelatin films with improved barrier properties |
| 07/27/2006 | US20060165773 Gene therapy of tumors using non-viral delivery system |
| 07/27/2006 | US20060165772 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
| 07/27/2006 | US20060165771 Compositions for delivery of drug combinations |
| 07/27/2006 | US20060165770 Lipid particles having asymmetric lipid coating and method of preparing same |
| 07/27/2006 | US20060165769 Pharmaceutical formulations containing vitamin E TPGS molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations |
| 07/27/2006 | US20060165768 Phosphoramide type cationic lipid compounds such as 3-[[bis(tetradecyloxy)phosphoryl](methyl)amino]-N,N,N-trimethyl-propanaminium iodide; use as nonviral vectors for gene transfer |
| 07/27/2006 | US20060165767 Thermolabile liposome with a controlled release temperature |
| 07/27/2006 | US20060165766 Liposomes encapsulate active agent; vehicles for the delivery of drugs and active agents as well as in the field of gene transfer; delayed, sustained or prolonged release, gradual release, timed release, pH dependent release |
| 07/27/2006 | US20060165765 Topical glycopyrrolate product |
| 07/27/2006 | US20060165763 Pasting agent |
| 07/27/2006 | US20060165760 Composite flexible transpirable device formed from separate layers of textile material joined together by a layer of adhesive polymer |
| 07/27/2006 | US20060165759 Antacid lozenge containing micronized particles |
| 07/27/2006 | US20060165749 Moisture-activated release of fragrances from novel pourable lotion formulations |
| 07/27/2006 | US20060165744 Combination liposomal formulations |
| 07/27/2006 | US20060165742 Powdery active ingredient formulations |
| 07/27/2006 | US20060165735 Stable emulsions of oils in aqueous solutions and methods for producing same |
| 07/27/2006 | US20060165734 Novel method of deodorization for fat odor and composition obtained by the same |
| 07/27/2006 | US20060165733 Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol |
| 07/27/2006 | US20060165726 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like |
| 07/27/2006 | US20060165709 stimulate T cytotoxic lymphocytes in a mammal |
| 07/27/2006 | US20060165708 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 07/27/2006 | US20060165707 Substances |
| 07/27/2006 | US20060165674 Granular composition and process for producing the same |
| 07/27/2006 | US20060165673 proteins having transferase activity comprising amino acid sequences modified to be in detectably labeled form, used for therapy and drug screening |
| 07/27/2006 | US20060165659 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells |
| 07/27/2006 | US20060165657 Method for delivery of cosmetic by topical application |
| 07/27/2006 | US20060165656 Medicinal preparation having chemotherapeutic encapsulated therein |
| 07/27/2006 | US20060165643 Cosmetic or dermopharmaceutical compositions containing kombucha |
| 07/27/2006 | US20060165614 Palatable micro-capsules |
| 07/27/2006 | US20060165608 Ethyl 3-mercaptobutyrate as a flavoring or fragrance agent and methods for preparing and using same |
| 07/27/2006 | US20060165607 Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 07/27/2006 | US20060165606 Perforated microstructure; efficiently depositing compound at site of action; minimizing toxic side effects, lowering dosing requirements |
| 07/27/2006 | US20060165605 Process to regenerate fcc spent catalyst |
| 07/27/2006 | US20060165604 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; migraines |
| 07/27/2006 | US20060165603 Solubilisation of drugs in hfa propellant by means of emulsions |
| 07/27/2006 | US20060165602 Method for deterring abuse of opioids by combination with non-release formulation of emetic |
| 07/27/2006 | US20060163101 Disposable package for liquid, pasty or powder product |
| 07/27/2006 | US20060163071 for controlling the flow of charged particles in an electrolyte; apparatus comprises an electrolytic bath container divided by a polymeric membrane foil into first and second compartments, wherein each compartment comprises an electrode connected to voltage supply |
| 07/27/2006 | US20060162722 Therapeutic aerosol device |
| 07/27/2006 | DE20023827U1 Pharmazeutische Gel-Zusammensetzung A pharmaceutical gel composition |
| 07/27/2006 | DE19853729B4 Verwendung einer im Magen-Darm-Kanal eines Tieres zerfallenden, knetbaren Trägerzusammensetzung Use of a gastro-intestinal tract of an animal decaying, malleable carrier composition |
| 07/27/2006 | DE102005003010A1 Copolymere für kosmetische Mittel, hergestellt in Gegenwart polyfunktioneller Regler Copolymers for cosmetics, in the presence of polyfunctional regulator |
| 07/27/2006 | DE10024396B4 Pflasterabdeckung für Kinder Paving coverage to children |
| 07/27/2006 | CA2595496A1 Medicament that is intended for oral administration, comprising a cyclooxygenase-2 inhibitor, and preparation method thereof |
| 07/27/2006 | CA2595483A1 Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
| 07/27/2006 | CA2595481A1 A tetracycline metal complex in a solid dosage form |
| 07/27/2006 | CA2595470A1 Pharmaceutical formulations and methods of use |
| 07/27/2006 | CA2595237A1 Stable prostaglandin-containing compositions |
| 07/27/2006 | CA2595084A1 Method for coating particle with lipid film |
| 07/27/2006 | CA2595063A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | CA2595043A1 Use of oxycodone for treating visceral pain |
| 07/27/2006 | CA2594981A1 Anthelmintic composition |
| 07/27/2006 | CA2594880A1 Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms |
| 07/27/2006 | CA2593359A1 Direct compression formulation and process |
| 07/27/2006 | CA2593112A1 Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion |
| 07/27/2006 | CA2592269A1 Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate |
| 07/27/2006 | CA2591944A1 Metal containing composite materials |
| 07/27/2006 | CA2575988A1 Methods for manufacturing delivery devices and devices thereof |
| 07/26/2006 | EP1683812A1 Crosslinked polysaccharide microparticles and method for their preparation |
| 07/26/2006 | EP1683560A1 Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product |
| 07/26/2006 | EP1683528A1 Polysaccharide-containing composition and tear film stabilizing ophthalmic solution |
| 07/26/2006 | EP1683526A1 Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
| 07/26/2006 | EP1683525A1 Sustained-release phenylalanine derivative preparation for oral administration |
| 07/26/2006 | EP1683524A1 Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative |
| 07/26/2006 | EP1683518A1 Pharmaceutical formulation of a stable formoterol-containing propylene glycol solution for use in inhalation therapy and method of preparing it |
| 07/26/2006 | EP1683517A1 Methods for the production of protein particles useful for delivery of pharmacological agents |
| 07/26/2006 | EP1683516A2 Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
| 07/26/2006 | EP1683515A2 Bismuth-containing compounds in topical dosage forms |
| 07/26/2006 | EP1683514A1 Concentrated suspensions of drugs and their use to produce suspensions for inhalatory administration |
| 07/26/2006 | EP1683507A1 A method and apparatus for manufacturing dissolvable tablets |
| 07/26/2006 | EP1682568A2 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 07/26/2006 | EP1682552A1 Tocopherol-modified therapeutic drug compounds |
| 07/26/2006 | EP1682491A1 Non-symmetrical gelling agent |
| 07/26/2006 | EP1682211A1 Transdermal drug delivery method and system |
| 07/26/2006 | EP1682185A2 Compositions and methods for treating a posterior segment of an eye |
| 07/26/2006 | EP1682184A1 Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
| 07/26/2006 | EP1682165A1 Use of interferon-tau in medicine |
| 07/26/2006 | EP1682161A1 Polymerizable emulsions for tissue engineering |
| 07/26/2006 | EP1682149A2 Injectable gabapentin compositions |
| 07/26/2006 | EP1682146A1 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 07/26/2006 | EP1682144A1 Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties |
| 07/26/2006 | EP1682137A1 Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain |
| 07/26/2006 | EP1682132A1 Transscleral delivery |
| 07/26/2006 | EP1682130A1 Novel compositions |
| 07/26/2006 | EP1682119A1 Discodermolide compositions |
| 07/26/2006 | EP1682116A1 Method for preparing submicron particles of paclitaxel |
| 07/26/2006 | EP1682102A2 Multi-layer transdermal drug delivery device |